4.7 Article

Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment

期刊

SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/srep45627

关键词

-

资金

  1. Russian Science Foundation [14-23-00160]
  2. Russian Science Foundation [17-23-00013] Funding Source: Russian Science Foundation

向作者/读者索取更多资源

A new group of compounds, promising for the design of original multitarget therapeutic agents for treating neurodegenerative diseases, based on conjugates of aminoadamantane and carbazole derivatives was synthesized and investigated. Compounds of these series were found to interact with a group of targets that play an important role in the development of this type of diseases. First of all, these compounds selectively inhibit butyrylcholinest erase, block NMDA receptors containing NR2B subunits while maintaining the properties of MK-801 binding site blockers, exert microtubules stabilizing properties, and possess the ability to protect nerve cells from death at the calcium overload conditions. The leading compound C-2h has been shown the most promising effects on all analyzed parameters. Thus, these compounds can be regarded as promising candidates for the design of multitarget disease-modifying drugs for treatment of AD and/or similar neuropathologies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

3-(2-Arylhydrazono)-1,1,1-trifluro-3-(phenylsulfonyl)propan-2-ones as selective carboxylesterase inhibitors

E. Shchegolkov, N. P. Boltneva, Ya Burgart, S. Lushchekina, O. G. Serebryakova, N. A. Elkina, E. Rudakova, A. N. Perminova, G. F. Makhaeva, V. Saloutin

Summary: This study improved the synthetic procedure for a compound and established its structure. The esterase profile of the compound showed no inhibition against cholinesterase and high activity against carboxylesterase. Additionally, the compound exhibited strong radical-scavenging effect.

RUSSIAN CHEMICAL BULLETIN (2022)

Article Biochemistry & Molecular Biology

Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease

Galina F. F. Makhaeva, Nadezhda V. V. Kovaleva, Elena V. V. Rudakova, Natalia P. P. Boltneva, Maria V. V. Grishchenko, Sofya V. V. Lushchekina, Tatiana Y. Y. Astakhova, Olga G. G. Serebryakova, Elena N. N. Timokhina, Ekaterina F. F. Zhilina, Evgeny V. V. Shchegolkov, Mariya V. V. Ulitko, Eugene V. V. Radchenko, Vladimir A. A. Palyulin, Yanina V. V. Burgart, Victor I. I. Saloutin, Sergey O. O. Bachurin, Rudy J. J. Richardson

Summary: The conjugates of tacrine and salicylamide with varied structure of the salicylamide fragment and salicylic aldehyde derivatives showed broad-spectrum biological activity. These hybrids exhibited potent inhibition towards acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with selectivity towards BChE. The most active compounds were salicylimine derivatives, which showed potential to block AChE-induced beta-amyloid aggregation. These synthesized conjugates are promising multifunctional agents for the potential treatment of AD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Biological Activity of Novel Organotin Compounds with a Schiff Base Containing an Antioxidant Fragment

Taisiya A. Antonenko, Yulia A. Gracheva, Dmitry B. Shpakovsky, Mstislav A. Vorobyev, Dmitrii M. Mazur, Victor A. Tafeenko, Yury F. Oprunenko, Elena F. Shevtsova, Pavel N. Shevtsov, Alexey A. Nazarov, Elena R. Milaeva

Summary: A series of novel organotin(IV) complexes based on 2-(N-3 ',5 '-di-tert-butyl-4'-hydroxyphenyl)-iminomethylphenol (L) were synthesized and characterized. The crystal structures of L and complex 2 were determined. The complexes exhibited antioxidant, antiproliferative, and apoptosis-inducing activities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease

Vyacheslav E. Semenov, Irina Zueva, Sofya Lushchekina, Eduard G. Suleimanov, Liliya M. Gubaidullina, Marina M. Shulaeva, Oksana A. Lenina, Konstantin A. Petrov

Summary: Novel derivatives based on 6-methyluracil and condensed uracil with terminal meta- and para-benzoate moieties in polymethylene chains were synthesized. They showed potential in decreasing beta-amyloid plaques and treating memory impairment in an Alzheimer's disease transgenic model.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Powerful Potential of Polyfluoroalkyl-Containing 4-Arylhydrazinylidenepyrazol-3-ones for Pharmaceuticals

Yanina V. V. Burgart, Natalia A. A. Elkina, Evgeny V. V. Shchegolkov, Olga P. P. Krasnykh, Galina F. F. Makhaeva, Galina A. A. Triandafilova, Sergey Yu. Solodnikov, Natalia P. P. Boltneva, Elena V. V. Rudakova, Nadezhda V. V. Kovaleva, Olga G. G. Serebryakova, Mariya V. V. Ulitko, Sophia S. S. Borisevich, Natalia A. A. Gerasimova, Natalia P. P. Evstigneeva, Sergey A. A. Kozlov, Yuliya V. V. Korolkova, Artem S. S. Minin, Anna V. V. Belousova, Evgenii S. S. Mozhaitsev, Artem M. M. Klabukov, Victor I. I. Saloutin

Summary: 4-Arylhydrazinylidene-5-(polyfluoroalkyl)pyrazol-3-ones (4-AHPs) were successfully synthesized and showed acceptable ADME profile. Varying the substituents in 4-AHPs allowed for changes in their biological activity, including anticarboxylesterase action, antioxidant properties, anti-cancer activity, and inhibition of bacterial growth. Some 4-AHPs also exhibited cell visualization capabilities and analgesic effects, while a mechanism involving blocking the TRPV1 receptor was proposed for their antinociceptive action.

MOLECULES (2023)

Article Biochemistry & Molecular Biology

Elaboration of the Effective Multi-Target Therapeutic Platform for the Treatment of Alzheimer's Disease Based on Novel Monoterpene-Derived Hydroxamic Acids

Yulia Aleksandrova, Aldar Munkuev, Evgenii Mozhaitsev, Evgenii Suslov, Dmitry Tsypyshev, Kirill Chaprov, Roman Begunov, Konstantin Volcho, Nariman Salakhutdinov, Margarita Neganova

Summary: Novel monoterpene-based hydroxamic acids were synthesized, consisting of compounds with a hydroxamate group directly bound to monoterpene scaffolds or connected through aliphatic or aromatic linkers. Some of these compounds showed powerful HDAC6 inhibitory activity, with a hexa- and heptamethylene linker and (-)-perill fragment exhibiting the most excellent activity. Moderate antiradical activity was also observed. Compounds with an aromatic linker based on para-substituted cinnamic acids demonstrated the ability to suppress aggregation of beta-amyloid peptide 1-42. The lead compound 35a showed neuroprotective effects on in vivo Alzheimer's disease models. This research suggests the potential use of monoterpene-derived hydroxamic acids in Alzheimer's disease treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Microwave-Assisted Synthesis of 3-Hydroxy-2-oxindoles and Pilot Evaluation of Their Antiglaucomic Activity

Alexander M. M. Efremov, Olga V. V. Beznos, Roman O. O. Eremeev, Natalia B. B. Chesnokova, Elena R. R. Milaeva, Elena F. F. Shevtsova, Natalia A. A. Lozinskaya

Summary: This article presents an efficient method for synthesizing novel 2-oxindole derivatives using microwave-assisted decarboxylative condensation. The compounds were found to regulate intraocular pressure and show potential antiglaucomic activity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Neurosciences

Nicotinic acetylcholine receptors and learning and memory deficits in Neuroinflammatory diseases

Valentina Echeverria, Cristhian Mendoza, Alex Iarkov

Summary: The survival of animals depends on their cognitive abilities, such as learning and memory, to adapt to the environment. Cotinine, a cholinergic modulator, has various beneficial effects, including neuroprotection, antidepressant, anti-inflammatory, antioxidant, and memory-enhancing effects. It exerts its positive effects on cognition by modulating the alpha 7-nicotinic acetylcholine receptors (nAChRs) and inhibiting toll-like receptors (TLRs). These receptors play a crucial role in brain functions, including neurotransmission and neuroinflammation. Understanding the mechanisms of memory formation and the actions of Cotinine in aging and neurological diseases is discussed in this article.

FRONTIERS IN NEUROSCIENCE (2023)

Review Biochemistry & Molecular Biology

Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases

Yulia Aleksandrova, Margarita Neganova

Summary: The relationship between oncological pathologies and neurodegenerative disorders is complex and has become a topic of interest among researchers. Recent scientific evidence suggests that various factors and processes contribute to the development of these diseases, revealing an intriguing connection between oncology and neurodegeneration. This review explores the links between oxidative stress, epigenetic dysregulation, and metabolic dysfunction in detail, and discusses the potential therapeutic approaches in current research. This comprehensive analysis helps in the development of advanced diagnostic tools and innovative pharmacological strategies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus

Ivan M. Veselov, Daria V. Vinogradova, Andrey V. Maltsev, Pavel N. Shevtsov, Elena A. Spirkova, Sergey O. Bachurin, Elena F. Shevtsova

Summary: This review focuses on the common features connecting metabolic disorders and type 2 diabetes with the development of Alzheimer's disease. The pathogenesis of Alzheimer's disease overlaps with the mechanisms of type 2 diabetes, and aging is an important risk factor for both diseases. Common pathological mechanisms include oxidative stress, neuroinflammation, insulin resistance, and amyloidosis, as well as mitochondrial dysfunctions and cell death. The available drugs for type 2 diabetes and Alzheimer's disease have limited efficacy, highlighting the need for new treatment strategies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Chemistry, Multidisciplinary

Multipharmacophore strategy in medicinal chemistry for the design of drugs for the treatment of Alzheimer's and some other neurodegenerative diseases

S. O. Bachurin, A. Yu. Aksinenko, G. F. Makhaeva, E. F. Shevtsova

Summary: A strategy for designing potential drugs for neurodegenerative diseases is discussed, which involves combining multiple structural moieties of neuroactive substances within a single molecule. Synthetic approaches to these compounds are considered and exemplified by the synthesis of conjugates of specific moieties linked through spacers. The biological activity of the compounds, including their effects on enzyme systems, receptors, mitochondrial structures, microtubule systems, and antioxidant properties, is evaluated. The results provide new opportunities for the design of highly efficient multitarget drugs, as evidenced by the selection of leading compounds that have passed preclinical trials.

RUSSIAN CHEMICAL BULLETIN (2023)

Article Biochemistry & Molecular Biology

New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments

Maria A. Lapshina, Elena F. Shevtsova, Vladimir V. Grigoriev, Aleksey Yu. Aksinenko, Aleksey A. Ustyugov, Daniil A. Steinberg, Grigoriy V. Maleev, Elena S. Dubrovskaya, Tatiana V. Goreva, Tatiana A. Epishina, Vladimir L. Zamoyski, Galina F. Makhaeva, Vladimir P. Fisenko, Ivan M. Veselov, Daria V. Vinogradova, Sergey O. Bachurin

Summary: The study aims to modify the structural core of the Edaravone-phenylpyrazolone moiety and combine it with aminoadamantane pharmacophore to expand its action against the pathogenesis of ALS. New conjugates of edaravone derivatives with 1-aminoadamantanes were synthesized, showing inhibitory effects on lipid peroxidation, calcium-related mitochondrial permeability, and CNS neuronal currents, as well as reducing aggregation of mutated FUS-protein. These findings are significant for the development of new drugs for the treatment of ALS.

MOLECULES (2023)

暂无数据